Page 5 - SRPSKO DRUŠTVO ISTRAŽIVAČA RAKA
P. 5
CONTENTS
ONCOLOGY INSIGHTS INFO ................................................................................................................................I
AUTHOR GUIDELINES .........................................................................................................................................II
LEGACY INSIGHTS ...............................................................................................................................................1
PATIENT POINT OF VIEW ....................................................................................................................................7
FUTURE HORIZONS IN CANCER ...................................................................................................................... 13
ORIGINAL ARTICLES ........................................................................................................................................ 23
PERSONAL POINT OF VIEW ............................................................................................................................. 31
PROCEEDINGS BOOK ...................................................................................................................................... 37
POSTER SESSION ........................................................................................................................................ 85
SESSION 1: Benefits of combination therapies in cancer treatment .................................................... 85
SESSION 2: Personalized anticancer treatment through targeting signaling pathways ...................... 88
SESSION 3: Tumor microenvironment - friend of foe ............................................................................ 99
SESSION 4: Immunooncology .............................................................................................................. 104
SESSION 5: Exploring the role of mdr mechanisms and stem cell biology in cancer and cancer
treatment strategies ........................................................................................................................... 107
SESSION 6: Cancer epidemiology- strategies for prevention and early detection .............................. 108
SESSION 7: Advancements in molecular diagnostics and cancer biomarkers in oncology ................ 114
SESSION 8: Liquid biopsy ..................................................................................................................... 120
SESSION 9: Clinical oncology - bridging patients and researchers ..................................................... 126
SESSION 10: Bioinformatics and cancer genomics ............................................................................. 132
SESSION 11: Novel cancer therapies and drug development strategies ............................................ 139
SESSION 12: Toxic triggers: enviromental chemicals and cancer risk ................................................. 154
SESSION 13: Tumor metabolism ......................................................................................................... 155
SESSION 14: Innovative models and approaches in cancer research ................................................. 162
